Patients with the deadliest form of brain cancer who received a focused ultrasound treatment to aid drug delivery increased their odds of survival by nearly 40%, according to research led by University of Maryland School of Medicine researchers.

Subscribe to continue reading this article.

Already subscribed? To log in, click here.

See Full Page